I’ve spent the past 12 years at the intersection of healthcare, life sciences, science, and venture capital — first as a scientist, then as a founder, and now as an Investment Director at a €150M+ AUM impact VC fund. Along the way, I’ve reviewed 500+ investment opportunities and worked closely with founders as they navigate some of the hardest moments of building a company: proving the value of their science, finding product-market fit, and raising the capital needed to move forward. Because I’ve been on both sides of the table, I know how difficult it can be to turn complex science into a story that investors immediately understand and believe in. I now work with early-stage biotech, medtech, and digital health founders to sharpen their equity story, clarify their value proposition, and build a fundraising strategy that stands up in a VC room. My goal is simple: help great science become an investable, compelling business.